Clinical Efficacy Of Cabozantinib Plus Nivolumab (Cabonivo) And Cabonivo Plus Ipilimumab (Cabonivoipi) In Patients (Pts) With Chemotherapy-Refractory Metastatic Urothelial Carcinoma (Muc) Either Naive (N) Or Refractory (R) To Checkpoint Inhibitor (Cpi)
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要